Quote:

---

Maybe Ohm or someone else can speak to whether there's a chance Leron has a chance to show any effect in this way. I'm reminded of the patients apparently lost to follow up in the mtnbc trial that might have been able to show a longer overall survival rate had anyone thought to track them past 12+ months.

---

That would make an interesting side note but that cancer progression is so virulent it wouldn't have much relevance unless other NASH studies have done the same and can be used for comparison.

Quote:

---

I'm reminded of the patients apparently lost to follow up in the mtnbc trial that might have been able to show a longer overall survival rate had anyone thought to track them past 12+ months.

---

Follow up on patients would have to be done after the trial for a period of time as specified in the protocol. Probably one or two years in a cancer trial. So the data should be there and Cytodyn would have it after getting all the raw data from Amarex.